Know Cancer

or
forgot password

Exercise During the Allogeneic Stem Cell Transplantation


Phase 3
18 Years
70 Years
Open (Enrolling)
Both
Fatigue, Allogeneic Stem Cell Transplantation

Thank you

Trial Information

Exercise During the Allogeneic Stem Cell Transplantation


Inclusion Criteria:



- Neoplastic malignancy

- Allogeneic peripheral stem cell transplantation

- Proficiency in German

Exclusion Criteria:

- Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can
be aggravated by exercise

- Pathological stress-ECG at admission

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care

Outcome Measure:

VO2max

Outcome Time Frame:

At recruitment and after 4 weeks

Safety Issue:

No

Principal Investigator

Fernando Dimeo, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Charite University, Berlin, Germany

Authority:

Germany: Ethics Commission

Study ID:

EA4/030/09

NCT ID:

NCT00883714

Start Date:

May 2009

Completion Date:

August 2011

Related Keywords:

  • Fatigue
  • Allogeneic Stem Cell Transplantation
  • Exercise
  • sport
  • Allogeneic blood stem cell transplantation
  • Blood stem cell transplantation
  • Fatigue
  • Cancer
  • Physical performance
  • Mood
  • Complications
  • Fatigue

Name

Location